Clinical Trial Update: Assessing the Utility of Plasma ctHPVDNA for Anal Cancer Screening

View source ↗

Summary

A clinical trial update describes a study evaluating plasma ctHPVDNA as a screening tool for anal cancer in individuals with anal dysplasia, sponsored by Massac…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anal Dysplasia

Snippet

Sponsor: Massachusetts Eye and Ear Infirmary | Conditions: Anal Dysplasia | Status: ACTIVE_NOT_RECRUITING